Researchers in Finland have identified a new mechanism that regulates the detrimental structural changes in breast cancer tissue, potentially leading to new treatments for aggressive forms of the disease.
A research team at Åbo Akademi in Finland has uncovered a novel mechanism that controls the harmful modifications of breast cancer tissue, which promote the disease's progression. This discovery, as announced by ÅA, may pave the way for the development of new therapeutic strategies targeting aggressive forms of breast cancer that currently lack targeted treatment options. The breakthrough was led by Professor Cecilia Sahlgren's inFlames group, which studies the human immune and defense systems.
Breast cancer remains the most common form of cancer among women worldwide. The prognosis for localized breast cancer identified early is typically favorable, but the outlook worsens significantly for cases where the cancer has metastasized to other tissues. This new finding highlights the importance of understanding the mechanisms at play in breast cancer dynamics, particularly the role of specific proteins that are expressed in malignant, hormone-independent types of this cancer.
The study focuses on a protein known as Jagged1, which plays a crucial role in cell communication and has previously been linked to malignant breast cancer forms. The Åbo Akademi researchers aim to explore further how this protein may contribute to the aggressive characteristics of certain breast cancers, with an emphasis on novel treatment approaches that could improve outcomes for patients with limited current options.
